Share this article
The subsidiary provides CDMO services, utilizing 57,000 sq. ft. of laboratory space and cutting-edge process chemistry technology in Princeton South, New Jersey and Richmond, Virginia.
KOLKATA, India, Feb. 4, 2021 /PRNewswire/
TCG GreenChem provides high-end, integrated CMC services covering development to cGMP clinical trial supplies
TCG GreenChem will accelerate the transition of drug candidates through the development pipeline efficiently and economically utilizing innovative catalysis and continuous flow chemistry technologies
TCG GreenChem will be seamlessly integrated with TCG Lifesciences India operations to serve its global customers across the full range of discovery, development, and commercial applications
TCG Greenchem
TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group ( TCG ), has announced today the expansion of its operations in the USA with the establishment of TCG GreenChem Inc., a subsidiary of TCG Li
Purdue Creditors Zero In on Sackler Messages From a Decade Ago By Jef Feeley, Jeremy Hill and Valerie Bauman | December 29, 2020
Bankruptcy creditors are pointing to a trove of decade-old documents as they probe whether members of the billionaire Sackler family improperly took funds out of Purdue Pharma LP, the maker of OxyContin, to keep the assets away from victims of the U.S. opioid epidemic.
Creditors including U.S. states, cities and counties cite recently unsealed memos and emails involving the Sacklers, whose company has twice pleaded guilty to illegally marketing OxyContin painkillers. Creditors say the documents are among “powerful circumstantial evidence” that the Sacklers were worried as early as 2007 about being sued personally and discussed ways to protect their fortunes.